KROS Return on Tangible Equity | Keros Therapeutics, Inc.

Keros Therapeutics, Inc. (KROS) Return on Tangible Equity

2026-06-30: Return Tang Equity -31.70%.
2026-03-31: Return Tang Equity -29.81%.
2025-12-31: Return Tang Equity 28.70%.
2025-09-30: Return Tang Equity 9.16%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-31.70%
2026-03-31	-29.81%
2025-12-31	28.70%
2025-09-30	9.16%
2025-06-30	2.66%
2025-03-31	0.58%
2024-12-31	-32.78%
2024-09-30	-34.08%
2024-06-30	-39.93%
2024-03-31	-35.31%
2023-12-31	-46.05%
2023-09-30	-48.16%
2023-06-30	-38.78%
2023-03-31	-32.76%
2022-12-31	-37.73%
2022-09-30	-33.98%
2022-06-30	-37.26%
2022-03-31	-30.00%
2021-12-31	-24.16%
2021-09-30	-28.60%
2021-06-30	-23.01%
2021-03-31	-19.87%
2020-12-31	-17.33%
2020-09-30	-28.63%
2020-06-30	-20.48%
2020-03-31	84.63%
2019-12-31	63.44%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	28.70%
2024-12-31	-32.78%
2023-12-31	-46.05%
2022-12-31	-37.73%
2021-12-31	-24.16%
2020-12-31	-17.33%
2019-12-31	63.44%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Cartesian Therapeutics, Inc. (RNAC)	United States	$0.231B	-2.04
NATURES SUNSHINE PRODUCTS INC (NATR)	United States	$0.228B	20.51
SIGA TECHNOLOGIES INC (SIGA)	United States	$0.234B	-93.33
Sionna Therapeutics, Inc. (SION)	United States	$0.236B	-20.37
Whitehawk Therapeutics, Inc. (WHWK)	United States	$0.221B
Eledon Pharmaceuticals, Inc. (ELDN)	United States	$0.219B	-3.23
Camp4 Therapeutics Corp (CAMP)	United States	$0.240B	-2.12
MACROGENICS INC (MGNX)	United States	$0.242B	-20.11
Cue Biopharma, Inc. (CUE)	United States	$0.243B	-1.01
Entrada Therapeutics, Inc. (TRDA)	United States	$0.243B	-1.73